Cargando…

The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A Gene

PURPOSE: To measure visual fields using two-color dark-adapted chromatic perimetry in a subset of participants in the Rate of Progression of USH2A-related Retinal Degeneration (RUSH2A), a study of USH2A-mediated syndromic (USH2) and autosomal recessive nonsyndromic retinitis pigmentosa, determine pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Birch, David G., Samarakoon, Lassana, Melia, Michele, Duncan, Jacque L., Ayala, Allison R., Audo, Isabelle, Cheetham, Janet K., Durham, Todd A., Iannaccone, Alessandro, Pennesi, Mark E., Stingl, Katarina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944389/
https://www.ncbi.nlm.nih.gov/pubmed/35293952
http://dx.doi.org/10.1167/iovs.63.3.17
_version_ 1784673703272906752
author Birch, David G.
Samarakoon, Lassana
Melia, Michele
Duncan, Jacque L.
Ayala, Allison R.
Audo, Isabelle
Cheetham, Janet K.
Durham, Todd A.
Iannaccone, Alessandro
Pennesi, Mark E.
Stingl, Katarina
author_facet Birch, David G.
Samarakoon, Lassana
Melia, Michele
Duncan, Jacque L.
Ayala, Allison R.
Audo, Isabelle
Cheetham, Janet K.
Durham, Todd A.
Iannaccone, Alessandro
Pennesi, Mark E.
Stingl, Katarina
author_sort Birch, David G.
collection PubMed
description PURPOSE: To measure visual fields using two-color dark-adapted chromatic perimetry in a subset of participants in the Rate of Progression of USH2A-related Retinal Degeneration (RUSH2A), a study of USH2A-mediated syndromic (USH2) and autosomal recessive nonsyndromic retinitis pigmentosa, determine percentage retaining rod function, and explore relationships between dark-adapted visual fields (DAVF) and rod function from ERG and full-field stimulus thresholds (FST). METHODS: Full-field rod mean sensitivity, number of rod loci, maximum sensitivity, DAVF full-field hill of vision (DAVF V(TOT)), and 30° hill of vision (DAVF V(30)) were measured in one eye for DAVF ancillary study participants (n = 49). Loci where cyan relative to red sensitivity was more than 5 dB on dark-adapted chromatic perimetry were considered rod mediated. Correlation coefficients between the DAVF measures and standard clinical measures were estimated, as were kappa statistics (κ) for agreement between DAVF and other measures of rod function. RESULTS: Of 49 participants tested with DAVF, 38 (78%) had evidence of rod function, whereas 15 (31%) had measurable rod ERGs. DAVF maximum sensitivity was highly correlated with FST white thresholds (r = −0.80; P < .001). Although not statistically significant, the number of rod loci and DAVF V(TOT) were lower in eyes with longer disease duration by 0.82 (95% confidence interval, −1.76, 0.12) loci/year and 0.59 (95% confidence interval, −1.82, 0.64) dB-steradians/year, respectively. CONCLUSIONS: Rod-mediated function on FST and DAVF is present in many patients with symptomatic USH2A-related retinal degeneration, including some without measurable rod ERGs. RUSH2A longitudinal data will determine how these measures change with disease progression and whether they are useful for longitudinal studies in inherited retinal degenerations.
format Online
Article
Text
id pubmed-8944389
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Association for Research in Vision and Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-89443892022-03-25 The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A Gene Birch, David G. Samarakoon, Lassana Melia, Michele Duncan, Jacque L. Ayala, Allison R. Audo, Isabelle Cheetham, Janet K. Durham, Todd A. Iannaccone, Alessandro Pennesi, Mark E. Stingl, Katarina Invest Ophthalmol Vis Sci Retina PURPOSE: To measure visual fields using two-color dark-adapted chromatic perimetry in a subset of participants in the Rate of Progression of USH2A-related Retinal Degeneration (RUSH2A), a study of USH2A-mediated syndromic (USH2) and autosomal recessive nonsyndromic retinitis pigmentosa, determine percentage retaining rod function, and explore relationships between dark-adapted visual fields (DAVF) and rod function from ERG and full-field stimulus thresholds (FST). METHODS: Full-field rod mean sensitivity, number of rod loci, maximum sensitivity, DAVF full-field hill of vision (DAVF V(TOT)), and 30° hill of vision (DAVF V(30)) were measured in one eye for DAVF ancillary study participants (n = 49). Loci where cyan relative to red sensitivity was more than 5 dB on dark-adapted chromatic perimetry were considered rod mediated. Correlation coefficients between the DAVF measures and standard clinical measures were estimated, as were kappa statistics (κ) for agreement between DAVF and other measures of rod function. RESULTS: Of 49 participants tested with DAVF, 38 (78%) had evidence of rod function, whereas 15 (31%) had measurable rod ERGs. DAVF maximum sensitivity was highly correlated with FST white thresholds (r = −0.80; P < .001). Although not statistically significant, the number of rod loci and DAVF V(TOT) were lower in eyes with longer disease duration by 0.82 (95% confidence interval, −1.76, 0.12) loci/year and 0.59 (95% confidence interval, −1.82, 0.64) dB-steradians/year, respectively. CONCLUSIONS: Rod-mediated function on FST and DAVF is present in many patients with symptomatic USH2A-related retinal degeneration, including some without measurable rod ERGs. RUSH2A longitudinal data will determine how these measures change with disease progression and whether they are useful for longitudinal studies in inherited retinal degenerations. The Association for Research in Vision and Ophthalmology 2022-03-16 /pmc/articles/PMC8944389/ /pubmed/35293952 http://dx.doi.org/10.1167/iovs.63.3.17 Text en Copyright 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
spellingShingle Retina
Birch, David G.
Samarakoon, Lassana
Melia, Michele
Duncan, Jacque L.
Ayala, Allison R.
Audo, Isabelle
Cheetham, Janet K.
Durham, Todd A.
Iannaccone, Alessandro
Pennesi, Mark E.
Stingl, Katarina
The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A Gene
title The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A Gene
title_full The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A Gene
title_fullStr The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A Gene
title_full_unstemmed The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A Gene
title_short The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A Gene
title_sort rush2a study: dark-adapted visual fields in patients with retinal degeneration associated with biallelic variants in the ush2a gene
topic Retina
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944389/
https://www.ncbi.nlm.nih.gov/pubmed/35293952
http://dx.doi.org/10.1167/iovs.63.3.17
work_keys_str_mv AT birchdavidg therush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene
AT samarakoonlassana therush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene
AT meliamichele therush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene
AT duncanjacquel therush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene
AT ayalaallisonr therush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene
AT audoisabelle therush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene
AT cheethamjanetk therush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene
AT durhamtodda therush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene
AT iannacconealessandro therush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene
AT pennesimarke therush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene
AT stinglkatarina therush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene
AT therush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene
AT birchdavidg rush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene
AT samarakoonlassana rush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene
AT meliamichele rush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene
AT duncanjacquel rush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene
AT ayalaallisonr rush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene
AT audoisabelle rush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene
AT cheethamjanetk rush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene
AT durhamtodda rush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene
AT iannacconealessandro rush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene
AT pennesimarke rush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene
AT stinglkatarina rush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene
AT rush2astudydarkadaptedvisualfieldsinpatientswithretinaldegenerationassociatedwithbiallelicvariantsintheush2agene